首页> 外文期刊>Modern Pathology >Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival
【24h】

Mucinous carcinoma of the colon: correlation of loss of mismatch repair enzymes with clinicopathologic features and survival

机译:结肠黏液癌:错配修复酶的丢失与临床病理特征和生存的相关性

获取原文
           

摘要

Colorectal carcinoma with microsatellite instability (MSI-H) has a characteristic clinicopathologic profile, typically forming right-sided, lymphocyte-rich tumors that are often mucinous. Mucinous histology in general has been linked to adverse prognosis in some studies, but not in others. MSI-H carcinoma, in contrast, has a better prognosis than microsatellite stable carcinoma in most studies. We assessed the relationship between MSI status, clinicopathologic features and outcome for 248 consecutive patients with resected mucinous carcinoma. All cases were reviewed to confirm mucinous histology. Immunohistochemical stains for DNA mismatch repair enzymes hMLH1, hMSH2 and hMSH6 were performed on a representative block from each case. Tumors lacking expression of a mismatch repair enzyme were designated MSI-H; all others were classified as microsatellite stable. Age, sex, tumor size, site, grade, stage, growth pattern, Crohn's-like reaction, vascular invasion and number of tumor-infiltrating lymphocytes were evaluated without knowledge of MSI status or patient outcome. 72 (29.3%) mucinous carcinomas were MSI-H. Compared to microsatellite stable mucinous cancers, they were more likely to be right-sided (83.3 vs 48.6%, Pvs 29.8%, Pvs 20.8%, Pvs 38.1%, Pvs 44.9%) or distant (4.2 vs 16.5%) metastases. In univariate analysis, MSI had a favorable effect on age-adjusted survival (hazard ratio 0.597, P=0.02). In multivariate analysis, age, grade, Crohn's-like reaction and stage were independent predictors of survival, but MSI status was not. In conclusion, MSI-H mucinous carcinomas are right-sided, low-stage tumors with Crohn's-like reaction and tumor-infiltrating lymphocytes. The outcome for MSI-H mucinous carcinoma is better than that of microsatellite-stable mucinous carcinoma, but MSI status is not an independent predictor of survival.
机译:具有微卫星不稳定性(MSI-H)的大肠癌具有典型的临床病理特征,通常形成右侧,富含淋巴细胞的肿瘤,通常是粘液性的。通常,在一些研究中粘液组织学与不良预后相关,而在其他研究中则没有。相反,在大多数研究中,MSI-H癌的预后优于微卫星稳定癌。我们评估了248例粘液癌切除患者的MSI状态,临床病理特征和预后之间的关系。回顾所有病例以确认粘液组织学。在每种情况下的代表性块上进行DNA错配修复酶hMLH1,hMSH2和hMSH6的免疫组织化学染色。缺少错配修复酶表达的肿瘤称为MSI-H;所有其他被归类为微卫星稳定。在不知道MSI状态或患者预后的情况下,评估了年龄,性别,肿瘤大小,部位,等级,阶段,生长方式,克罗恩氏样反应,血管浸润和肿瘤浸润淋巴细胞的数量。 MSI-H为72(29.3%)粘液癌。与微卫星稳定的粘液性癌症相比,它们更可能是右侧的(83.3 vs 48.6 %,Pvs 29.8 %,Pvs 20.8 %,Pvs 38.1 %,Pvs 44.9 %)或遥远的(4.2 vs 16.5 %)转移。在单因素分析中,MSI对年龄调整后的生存率具有良好的影响(危险比0.597,P = 0.02)。在多变量分析中,年龄,等级,克罗恩氏反应和阶段是生存的独立预测因素,但MSI状态不是。总之,MSI-H粘液癌是右侧,低期肿瘤,具有克罗恩氏样反应和肿瘤浸润淋巴细胞。 MSI-H粘液性癌的结局优于微卫星稳定粘液性癌,但MSI的状态不是生存的独立预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号